Jamshid Shirani

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

A mechanistic role for cardiac myocyte apoptosis in heart failure

Detlef Wencker, Madhulika Chandra, Khanh T. Nguyen et al. · Journal of Clinical Investigation · 2003 · 738 citations · Full text

Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death

Jamshid Shirani, Ruth Pick, William C. Roberts et al. · Journal of the American College of Cardiology · 2000 · 406 citations

Cardiomyopathy, Heart Failure, Structural Heart Disease +8

Caveolin-3 Knock-out Mice Develop a Progressive Cardiomyopathy and Show Hyperactivation of the p42/44 MAPK Cascade

Scott E. Woodman, David Park, Alex W. Cohen et al. · Journal of Biological Chemistry · 2002 · 289 citations · Full text

Cardiac Muscle, Heart Failure, P42/44 Mapk Cascade +21

Caveolin-1/3 Double-Knockout Mice Are Viable, but Lack Both Muscle and Non-Muscle Caveolae, and Develop a Severe Cardiomyopathic Phenotype

David Park, Scott E. Woodman, William Schubert et al. · American Journal Of Pathology · 2002 · 251 citations · Full text

Mechanobiology, Cardiac Muscle, Cardiomyopathy +11